Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nigel P Murray

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
Ecancermedicalscience|January 11, 2020
Common B-cell acute lymphoblastic leukaemia in a 70-year-old woman presenting 2 years after carboplatin-taxane radiotherapy for endometrial cancerNigel P Murray, Shenda Orrego, Marco Antonio López, et al.
Archivos Espanoles De Urologia|June 22, 2019
[Circulating prostate cells and bone marrow micrometastasis are determinant in risk and time to biochemical progression in localized prostate cancer.]Nigel P Murray, Sócrates Aedo, Cynthia Fuentealba, et al.
Urologic Oncology|March 10, 2015
Head-to-head comparison of the Montreal nomogram with the detection of primary malignant circulating prostate cells to predict prostate cancer at initial biopsy in Chilean men with suspicion of prostate cancerNigel P Murray, Eduardo Reyes, Cynthia Fuentealba, et al.
BJU International|October 29, 2015
Prediction model for early biochemical recurrence after radical prostatectomy based on the Cancer of the Prostate Risk Assessment score and the presence of secondary circulating prostate cellsNigel P Murray, Socrates Aedo, Eduardo Reyes, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|July 31, 2015
Comparison of the Formula of PSA, Age, Prostate Volume and Race Versus PSA Density and the Detection of Primary Malignant Circulating Prostate Cells in Predicting a Positive Initial Prostate Biopsy in Chilean Men with Suspicion of Prostate CancerNigel P Murray, Eduardo Reyes, Cynthia Fuentealba, et al.
Archivos Espanoles De Urologia|July 1, 2010
Detection and characteristics of primary circulating prostate cells; association with micrometastasis and implications for surgical treatment of men with prostate cancerNigel P Murray, Eduardo Reyes, Leonardo Badínez, et al.
Turkish Journal of Urology|July 25, 2020
The Epstein criteria predict for organ-confined prostate cancer but not for minimal residual disease and outcome after radical prostatectomyNigel P Murray, Cynthia Fuentealba, Eduardo Reyes, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|August 12, 2016
Does the Presence of Primary Circulating Prostate Cells Imply the Presence of Agressive Prostate Cancer with Early Biochemical Failure: a Comparison with the Walz NomogramNigel P Murray, Eduardo Reyes, Nelson Orellana, et al.
Archivos Espanoles De Urologia|June 24, 2015
[Expression of P504S and matrix metalloproteinase-2 in circulating prostate cells disseminated as a result of transrectal ultrasound guided biopsy as determined by immunocytochemistry: Clinical implications]Nigel P Murray, Eduardo Reyes, Nelson Orellana, et al.
Ecancermedicalscience|July 24, 2018
The presence of secondary circulating prostate tumour cells determines the risk of biochemical relapse for patients with low- and intermediate-risk prostate cancer who are treated only with external radiotherapyNigel P Murray, Socrates Aedo, Cynthia Fuentealba, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Ecancermedicalscience|January 11, 2020
Common B-cell acute lymphoblastic leukaemia in a 70-year-old woman presenting 2 years after carboplatin-taxane radiotherapy for endometrial cancerNigel P Murray, Shenda Orrego, Marco Antonio López, et al.
Archivos Espanoles De Urologia|June 22, 2019
[Circulating prostate cells and bone marrow micrometastasis are determinant in risk and time to biochemical progression in localized prostate cancer.]Nigel P Murray, Sócrates Aedo, Cynthia Fuentealba, et al.
Urologic Oncology|March 10, 2015
Head-to-head comparison of the Montreal nomogram with the detection of primary malignant circulating prostate cells to predict prostate cancer at initial biopsy in Chilean men with suspicion of prostate cancerNigel P Murray, Eduardo Reyes, Cynthia Fuentealba, et al.
BJU International|October 29, 2015
Prediction model for early biochemical recurrence after radical prostatectomy based on the Cancer of the Prostate Risk Assessment score and the presence of secondary circulating prostate cellsNigel P Murray, Socrates Aedo, Eduardo Reyes, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|July 31, 2015
Comparison of the Formula of PSA, Age, Prostate Volume and Race Versus PSA Density and the Detection of Primary Malignant Circulating Prostate Cells in Predicting a Positive Initial Prostate Biopsy in Chilean Men with Suspicion of Prostate CancerNigel P Murray, Eduardo Reyes, Cynthia Fuentealba, et al.
Archivos Espanoles De Urologia|July 1, 2010
Detection and characteristics of primary circulating prostate cells; association with micrometastasis and implications for surgical treatment of men with prostate cancerNigel P Murray, Eduardo Reyes, Leonardo Badínez, et al.
Turkish Journal of Urology|July 25, 2020
The Epstein criteria predict for organ-confined prostate cancer but not for minimal residual disease and outcome after radical prostatectomyNigel P Murray, Cynthia Fuentealba, Eduardo Reyes, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|August 12, 2016
Does the Presence of Primary Circulating Prostate Cells Imply the Presence of Agressive Prostate Cancer with Early Biochemical Failure: a Comparison with the Walz NomogramNigel P Murray, Eduardo Reyes, Nelson Orellana, et al.
Archivos Espanoles De Urologia|June 24, 2015
[Expression of P504S and matrix metalloproteinase-2 in circulating prostate cells disseminated as a result of transrectal ultrasound guided biopsy as determined by immunocytochemistry: Clinical implications]Nigel P Murray, Eduardo Reyes, Nelson Orellana, et al.
Ecancermedicalscience|July 24, 2018
The presence of secondary circulating prostate tumour cells determines the risk of biochemical relapse for patients with low- and intermediate-risk prostate cancer who are treated only with external radiotherapyNigel P Murray, Socrates Aedo, Cynthia Fuentealba, et al.
Pageof 8